Literature DB >> 2729942

Interaction between oral ciprofloxacin and caffeine in normal volunteers.

D P Healy1, R E Polk, L Kanawati, D T Rock, M L Mooney.   

Abstract

The influence of multiple doses of ciprofloxacin on the disposition of caffeine and its major metabolite, paraxanthine, was investigated in healthy volunteers. Ten xanthine-free, fasting males were given 100 mg of caffeine orally 24 h before being given ciprofloxacin and again with the third dose of ciprofloxacin (750 mg administered every 12 h). Blood samples were serially collected after both doses of caffeine and after the first and last doses of ciprofloxacin. Ciprofloxacin significantly increased the half-life of caffeine (from 5.2 +/- 1.2 to 8.2 +/- 2.5 h) and the area under the caffeine concentration-time curve (from 16.3 +/- 6.6 to 25.9 +/- 7.8 micrograms.h/ml) while decreasing the total body clearance (from 106 +/- 41.6 to 58.2 +/- 28.8 ml/min per 1.73 m2). In addition, the rate of conversion of caffeine to paraxanthine was significantly delayed. There was no significant linear correlation between the urinary recovery of oxociprofloxacin at 0 to 12 h and the change in the area under the caffeine concentration-time curve. There was also a small but statistically significant increase in the area under the ciprofloxacin concentration-time curve during simultaneous administration of caffeine. We concluded that ciprofloxacin causes a significant increase in the half-life of caffeine and in the area under the caffeine concentration-time curve by reducing total body clearance. This interaction is due at least in part to a delay in the conversion of caffeine to paraxanthine. The clinical significance of these observations remains to be determined. Lastly, caffeine may alter the kinetics of ciprofloxacin, a possibility which should be more fully explored.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2729942      PMCID: PMC172463          DOI: 10.1128/AAC.33.4.474

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Gyrase-inhibitors impair caffeine elimination in man.

Authors:  A H Staib; S Harder; S Mieke; C Beer; W Stille; P Shah
Journal:  Methods Find Exp Clin Pharmacol       Date:  1987-03

2.  Pharmacokinetics of ofloxacin and theophylline alone and in combination.

Authors:  J B Fourtillan; J Granier; B Saint-Salvi; J Salmon; A Surjus; D Tremblay; M Vincent Du Laurier; S Beck
Journal:  Infection       Date:  1986       Impact factor: 3.553

3.  New synthetic quinolone antibacterial agents and serum concentration of theophylline.

Authors:  Y Niki; R Soejima; H Kawane; M Sumi; S Umeki
Journal:  Chest       Date:  1987-10       Impact factor: 9.410

4.  Influence of mexiletine on caffeine elimination.

Authors:  R Joeres; H Klinker; H Heusler; J Epping; E Richter
Journal:  Pharmacol Ther       Date:  1987       Impact factor: 12.310

5.  Impact of ciprofloxacin on theophylline clearance and steady-state concentrations in serum.

Authors:  J Schwartz; L Jauregui; J Lettieri; K Bachmann
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

6.  Increased theophylline concentrations secondary to ciprofloxacin.

Authors:  M J Rybak; S K Bowles; P H Chandrasekar; D J Edwards
Journal:  Drug Intell Clin Pharm       Date:  1987-11

7.  The influence of quinolone derivatives on theophylline clearance.

Authors:  W J Wijnands; T B Vree; C L van Herwaarden
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

8.  Enoxacin--a potent inhibitor of theophylline metabolism.

Authors:  J Beckmann; W Elsässer; U Gundert-Remy; R Hertrampf
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

9.  Quantitative assessment of caffeine partial clearances in man.

Authors:  A Lelo; J O Miners; R A Robson; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

10.  Effect of multiple dose oral ciprofloxacin on the pharmacokinetics of theophylline and indocyanine green.

Authors:  D E Nix; J M DeVito; M A Whitbread; J J Schentag
Journal:  J Antimicrob Chemother       Date:  1987-02       Impact factor: 5.790

View more
  22 in total

1.  Influence of sex on the pharmacokinetic interaction of fleroxacin and ciprofloxacin with caffeine.

Authors:  Myo-Kyoung Kim; Charles Nightingale; David Nicolau
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Pharmacokinetics of drugs in cystic fibrosis.

Authors:  M Spino
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

3.  Quantitative Prediction of Drug Interactions Caused by CYP1A2 Inhibitors and Inducers.

Authors:  Laurence Gabriel; Michel Tod; Sylvain Goutelle
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447

4.  Safety of fleroxacin coadministered with theophylline to young and elderly volunteers.

Authors:  M Parent; M St-Laurent; M LeBel
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  The aminoglycoside antibiotic kanamycin damages DNA bases in Escherichia coli: caffeine potentiates the DNA-damaging effects of kanamycin while suppressing cell killing by ciprofloxacin in Escherichia coli and Bacillus anthracis.

Authors:  Tina Manzhu Kang; Jessica Yuan; Angelyn Nguyen; Elinne Becket; Hanjing Yang; Jeffrey H Miller
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

Review 6.  Clinical pharmacokinetics of mexiletine.

Authors:  L Labbé; J Turgeon
Journal:  Clin Pharmacokinet       Date:  1999-11       Impact factor: 6.447

Review 7.  Health risks of herbal remedies.

Authors:  P A De Smet
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

8.  Lack of interaction between lomefloxacin and caffeine in normal volunteers.

Authors:  D P Healy; J R Schoenle; J Stotka; R E Polk
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

Review 9.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

10.  Nonparametric expectation maximisation (NPEM) population pharmacokinetic analysis of caffeine disposition from sparse data in adult caucasians: systemic caffeine clearance as a biomarker for cytochrome P450 1A2 activity.

Authors:  Dimiter Terziivanov; Kristina Bozhinova; Velislava Dimitrova; Ivanka Atanasova
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.